相关实验视频

Updated: May 9, 2025

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

神经干细胞衍生的小细胞外囊:神经疾病的新疗法方法

Mengyao Wang^1,2, Dongdong Chen^1,2, Renjie Pan^1,2

¹Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.

Frontiers in immunology

|May 1, 2025

概括

神经干细胞衍生的小细胞外囊泡 (NSC-sEVs) 为神经疾病提供了有前途的非细胞治疗方法. 这些囊泡有助于修复,表现出降低的免疫性,并且可以被设计为增强的治疗输送.

科学领域:

神经科学是一个神经科学.
再生医学是一种再生医学.
生物技术是生物技术.

背景情况:

神经干细胞 (NSCs) 对于通过膜信号传递进行神经修复至关重要.
来自NSC的小细胞外囊泡 (NSC-sEVs) 介导关键的修复机制.
与基于细胞的疗法相比,NSC-sEVs具有优势,包括较低的免疫性和更好的血脑屏障透.

研究的目的:

审查NSC-sEVs在神经系统疾病中的生物功能和治疗潜力.
探索NSC-sEV活动背后的分子机制.
讨论NSC-sEV的工程,以提高药物输送和临床应用.

主要方法:

在神经疾病模型中对NSC-sEV研究的文献综述.
对NSC-sEV属性的分析,包括免疫性,瘤性和生物分布.
检查NSC-sEV工程和临床翻译的策略.

主要成果:

NSC-sEVs调节神经微环境,促进NSC分化,并有助于神经/质成熟.
与NSC相比,NSC-sEV显示免疫性和瘤生成潜力降低.
工程NSC-sEV显示了提高生产,活动和准特异性的潜力.

结论:

NSC-sEVs代表了神经系统疾病的有前途的无细胞治疗替代方案.
需要进一步的研究和工程来克服广泛临床应用的局限性.
作为治疗神经疾病的先进药物输送平台,NSC-sEV具有显著的潜力.

关键词:

来自NSC的小细胞外囊泡.神经干细胞的神经干细胞神经系统疾病神经系统疾病神经保护性神经保护剂小小的细胞外囊泡.

更多相关视频

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Published on: April 4, 2022

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...